US ONCOLOGY INC - FORM 10-K - EX-32.1 - CERTIFICATION OF CHIEF EXECUTIVE OFFICER (906) - March 4, 2010

Attached files

file filename
EX-21 - SUBSIDIARIES OF THE REGISTRANT - US ONCOLOGY INCdex21.htm
EX-32.2 - CERTIFICATION OF CHIEF FINANCIAL OFFICER (906) - US ONCOLOGY INCdex322.htm
EX-31.2 - CERTIFICATION OF CHIEF FINANCIAL OFFICER (302) - US ONCOLOGY INCdex312.htm
EX-31.1 - CERTIFICATION OF CHIEF EXECUTIVE OFFICER (302) - US ONCOLOGY INCdex311.htm
10-K - FORM 10-K FOR THE FISCAL YEAR ENDED DECEMBER 31, 2009 - US ONCOLOGY INCd10k.htm

Exhibit 32.1

US ONCOLOGY HOLDINGS, INC. AND US ONCOLOGY, INC.

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Annual Report of US Oncology Holdings, Inc. (the “Company”) and US Oncology, Inc. on Form 10-K for the period ended December 31, 2009 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Bruce D. Broussard, Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

 

  (1)

The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

 

  (2)

The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company.

 

/s/ Bruce D. Broussard

Bruce D. Broussard,
Chief Executive Officer of US Oncology Holdings, Inc. and US. Oncology, Inc.
March 2, 2010

US ONCOLOGY INC Reports

Also read